Aspen sees risk and reward in Covid-19
Though Aspen does not have manufacturing operations in China, the virus outbreak will have consequences for company, says CEO
08 March 2020 - 00:11
Aspen Pharmacare's fortunes may finally be turning around but the coronavirus could have an impact on its business as people delay elective surgeries for fear of contracting the virus in hospital.
CEO Stephen Saad told shareholders at Aspen's interim results presentation that though the company does not have manufacturing operations in China, the virus outbreak would have consequences for it...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.